Eur Heart J 2022 Nov 01
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
Related Questions
New answer by at University of Texas Southwestern Medical School (May 31, 2023)
Patients with ICI myocarditis are treated with 1g solumedrol for 3-5 days and then transitioned to oral prednisone at 1mg/kg per day. In general, a slow prednisone taper is re...
New answer by at University of Texas Southwestern Medical School (May 31, 2023)
Since novel biomarkers are not yet clinically available in most practice settings, these are not yet routinely being checked though they certainly merit further investigation ...
New comment by at FibroFighters Foundation ( June 29, 2023)
Do you use tocilizumab? Or only if steroids fail?
I ask because tocilizumab has anti-cancer properties and can promote IL-12 - which enhances immune-mediated cancer effect, w...
Are there other measures, pharmocologic or adjunctive, that can be used or are under investigation to mitigate cardiotoxicity related to chemo- or rad...
New answer by at Phoenix Childrens Medical Group (March 11, 2024)
Although pediatric patients rarely have cardiac co-morbidities at the time of diagnosis, we also monitor and treat high blood pressures carefully and follow echos throughout t...